Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 May-Jun;26(3):506-12.
doi: 10.1111/j.1939-1676.2012.00914.x. Epub 2012 Apr 4.

Evaluation of the efficacy and safety of high dose short duration enrofloxacin treatment regimen for uncomplicated urinary tract infections in dogs

Affiliations
Free PMC article
Randomized Controlled Trial

Evaluation of the efficacy and safety of high dose short duration enrofloxacin treatment regimen for uncomplicated urinary tract infections in dogs

J L Westropp et al. J Vet Intern Med. 2012 May-Jun.
Free PMC article

Abstract

Background: Uncomplicated urinary tract infections (UTI) in dogs usually are treated with antimicrobial drugs for 10-14 days. Shorter duration antimicrobial regimens have been evaluated in human patients.

Hypothesis: A high dose short duration (HDSD) enrofloxacin protocol administered to dogs with uncomplicated UTI will not be inferior to a 14-day treatment regimen with amoxicillin-clavulanic acid.

Animals: Client-owned adult, otherwise healthy dogs with aerobic bacterial urine culture yielding ≥ 10(3) CFU/mL of bacteria after cystocentesis.

Methods: Prospective, multicenter, controlled, randomized blinded clinical trial. Enrolled dogs were randomized to group 1 (enrofloxacin 18-20 mg/kg PO q24h for 3 days) or group 2 (amoxicillin-clavulanic acid 13.75-25 mg/kg PO q12h for 14 days). Urine cultures were obtained at days 0, 10, and 21. Microbiologic and clinical cure rates were evaluated 7 days after antimicrobial treatment was discontinued. Lower urinary tract signs and adverse events also were recorded.

Results: There were 35 dogs in group 1 and 33 in group 2. The microbiologic cure rate was 77.1 and 81.2% for groups 1 and 2, respectively. The clinical cure rate was 88.6 and 87.9% for groups 1 and 2, respectively. Cure rates between groups did not differ according to the selected margin of noninferiority.

Conclusions and clinical importance: HDSD enrofloxacin treatment was not inferior to a conventional amoxicillin-clavulanic acid protocol for the treatment of uncomplicated bacterial UTI in dogs. Further research is warranted to determine if this protocol will positively impact owner compliance and decrease the emergence of antimicrobial resistance.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
All uropathogens cultured from all dogs at day 0. Group 1 dogs were treated with enrofloxacin for 3 days and group 2 dogs were treated with clavulanic acid-amoxicillin for 14 days.

References

    1. Ling GV. Therapeutic strategies involving antimicrobial treatment of the canine urinary tract. J Am Vet Med Assoc. 1984;185:1162–1164. - PubMed
    1. McGuire NC, Schulman R, Ridgway MD, Bollero G. Detection of occult urinary tract infections in dogs with diabetes mellitus. J Am Anim Hosp Assoc. 2002;38:541–544. - PubMed
    1. Litster A, Moss S, Platell J, Trott DJ. Occult bacterial lower urinary tract infections in cats—urinalysis and culture findings. Vet Microbiol. 2009;136:130–134. - PubMed
    1. Pressler BM, Bartges J. Urinary tract infections. In: Ettinger SJ, Feldman EC, editors. Textbook of Veterinary Internal Medicine. 7th ed. St. Louis, MO: Saunders Elsevier; 2010. pp. 2036–2047.
    1. Grauer GF. Urinary tract infections. In: Nelson RW, Couto CG, editors. Small Animal Internal Medicien. St. Louis, MO: Mosby Elsevier; 2009. pp. 664–665.

Publication types